Neuromonitoring and Neurodiagnostic Devices Market Is Forecast to Reach US$ 1,538.8 Million by 2019 at a CAGR of 8.0% from 2015 to 2019.
Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of EEG devices. Manufacturers such as Emotiv and Neurosky are introducing disruptive devices that can be used and interpreted easily by a user which is increasing awareness of neurological disorders at an unprecedented level. This will bring about a large demand for EEG devices in the near future.
View full press release